Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,230 | 94,206 | 106,030 | 74,365 | 63,902 |
| Marketable Securities | 284,006 | 295,042 | 264,127 | 271,423 | 244,828 |
| Receivables | 51,313 | 44,367 | 39,631 | 69,886 | 67,205 |
| TOTAL | $401,848 | $451,262 | $423,840 | $423,310 | $380,389 |
| Non-Current Assets | |||||
| PPE Net | 10,927 | 11,373 | 11,476 | 9,493 | 8,374 |
| Investments And Advances | 65,013 | 0 | 16,510 | 11,465 | 16,389 |
| Other Non-Current Assets | 12,041 | 10,849 | 9,752 | 9,948 | 9,075 |
| TOTAL | $87,981 | $22,222 | $37,738 | $30,906 | $33,838 |
| Total Assets | $489,829 | $473,484 | $461,578 | $454,216 | $414,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,689 | 6,504 | 8,884 | 5,622 | 4,745 |
| Accrued Expenses | 15,920 | 13,997 | 11,607 | 11,152 | 9,892 |
| TOTAL | $22,609 | $20,501 | $20,491 | $22,632 | $16,025 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,728 | 4,886 | 4,877 | 4,749 | 4,523 |
| TOTAL | $4,728 | $4,886 | $4,877 | $4,749 | $4,523 |
| Total Liabilities | $27,337 | $25,387 | $25,368 | $27,381 | $20,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,726 | 19,682 | 19,670 | 19,442 | 19,424 |
| Common Shares | 197 | 197 | 197 | 194 | 194 |
| Retained earnings | 163,740 | 154,549 | 147,513 | 143,368 | 117,357 |
| Other shareholders' equity | 146 | 163 | -12 | -257 | -398 |
| TOTAL | $462,492 | $448,097 | $436,210 | $426,835 | $393,679 |
| Total Liabilities And Equity | $489,829 | $473,484 | $461,578 | $454,216 | $414,227 |